[council] Next step on closed generics

[philippe.fouquart at orange.com]

Dear Councilors,
As we proceed with preparing for the Closed Generics facilitated dialogue and as noted in the Board's recent letter, the next step for the GNSO is to assemble a group of individuals who will participate in the dialogue. Noting that the Council small group suggested that no more than 6-8 individuals from the GNSO participate, and acknowledging that there are benefits to keeping the group as small as possible, Council leadership would like to propose that we aim for 6 seats, as follows:
*            1 seat from Council leadership (ex-officio)
*            1 seat from the SubPro PDP leadership team
*            1 seat from each GNSO Stakeholder Group
o            A Stakeholder Group can give its seat to another Stakeholder Group if it chooses to do so
o            Council will provide Stakeholder Groups with the criteria from the Small Team to support selection of individuals
o            Stakeholder Group's will make a selection according to their own procedures
With this proposal, the GAC would also have the opportunity to fill an equal number of seats (6), bringing total participation to 13 individuals (which is inclusive of the one member from the ALAC).  (The GAC may obviously also choose to appoint less than 6 members)

It is important to note that while the proposed approach is seemingly representative in nature, the Council has provided expectations that members should, "...contribute as independent individuals, bringing their individual experiences and expertise, and not serve as representatives of their respective community organization(s). The participants must commit to focusing on successfully developing a framework for closed generics, even if the end product is inconsistent with the goals or priorities of the participant or the participant's SO/AC/SG/C." There is also an expectation that the facilitated discussion will avoid discussion of the "edge outcomes" (i.e., of allowing closed generics without restrictions or limitations or prohibiting closed generics under any circumstance) and members should be prepared to engage accordingly.
Understanding that there may not be a perfect solution that all groups support equally, we hope that this proposal can be acceptable to all. If you are unable to support the proposal, please raise your concerns on the mailing list no later than August 17th (2 weeks from now).

Thank you.
Kind regards,

Philippe


_________________________________________________________________________________________________________________________

Ce message et ses pieces jointes peuvent contenir des informations confidentielles ou privilegiees et ne doivent donc
pas etre diffuses, exploites ou copies sans autorisation. Si vous avez recu ce message par erreur, veuillez le signaler
a l'expediteur et le detruire ainsi que les pieces jointes. Les messages electroniques etant susceptibles d'alteration,
Orange decline toute responsabilite si ce message a ete altere, deforme ou falsifie. Merci.

This message and its attachments may contain confidential or privileged information that may be protected by law;
they should not be distributed, used or copied without authorisation.
If you have received this email in error, please notify the sender and delete this message and its attachments.
As emails may be altered, Orange is not liable for messages that have been modified, changed or falsified.
Thank you.

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/council/attachments/20220803/08bbca26/attachment.html>